/C O R R E C T I O N — Spinogenix/
In the news release, Spinogenix to Present Complete Phase 2a Clinical Trial Results for SPG601, a First-in-Class Fragile X Syndrome Treatment, at AACAP Conference, issued 22-Oct-2025 by Spinogenix over PR Newswire, we are advised by the company that the second subhead, should read ” Dr. Craig Erickson, Spinogenix Chief Medical Advisor, to Receive Prestigious George […]